The primary U.S. antitrust regulator indicated it will approve of CVS Health Corp.'s pending $69 billion deal to acquire Aetna Inc. once both companies divest their Medicare Part D plans.
The Department of Justice wrote in a news release that the divestiture would "fully resolve the Department's competition concerns" related to the planned tie-up.
The release confirms earlier reports that the Justice Department was inclined to require both companies to off-load their Part D business.
Medicare Part D is private Medicare insurance that covers only drug benefits.
WellCare Health Plans Inc. agreed in September to acquire Aetna's Part D plans, effective Dec. 31.
"We are pleased to have reached an agreement with the DOJ that maintains the strategic benefits and value creation potential of our combination with Aetna," CVS Health President and CEO Larry Merlo wrote in a statement. "We are now working to complete the remaining state reviews."